Japan University News
Follow Japan University News

Press releases

Tags

Soka University

Kindai University

Ritsumeikan University

Kindai University 16 Soka University 4 Cancer Treatment 3 Cancer 3 Discovery 2 Education 2 Education News 2 Tumor 2 Japan University News 2 Japanese Universities 2 Cancer Research 1 Cancer Survival 1 Liver Cancer 1 Internship 1 Pests 1 Immune System 1 Telescope 1 Atacama Large Millimeter/submillimeter Array 1 Online Classes 1 Astrophysics 1 Nivolumab 1 Slack 1 Hepatocellular Carcinoma 1 Market Development 1 Opdivo 1 Cancer Cell 1 Animal Breeding 1 ASAIHL 1 DAIICHI SANKYO 1 Ritsumeikan University 1 National Astronomical Observatory of Japan 1 NAOJ 1 Immune Activation 1 Hoy Hoy Trap-A-Roach 1 Overseas Internship Program 1 Earth Cooperation 1 Cockroach 1 Ho Chi Minh City University of Technology and Education 1 Teikyo University 1 Transarterial chemoembolization 1 Chat Tools 1 Campus Platform 1 Development of Animals 1 Research Results 1 Fertilized Eggs 1 Nuclear Structure 1 Survival Rate 1 Japan 1 DNA 1 Galaxy 1 ALMA 1 Black Hole 1 Chemotherapy 1 Astronomy 1 Universe 1 University 1 Show all tags
Preclinical Stage Verification for Combined Use of a Drug Under Development with an Existing Drug to Stimulate the Immune System to Attack Cancer Cells - Kindai University

Preclinical Stage Verification for Combined Use of a Drug Under Development with an Existing Drug to Stimulate the Immune System to Attack Cancer Cells - Kindai University

Press releases   •   Nov 01, 2019 05:00 UTC

The research team from Kindai University's Faculty of Medicine, in cooperation with DAIICHI SANKYO COMPANY, LIMITED, have verified at the preclinical stage that using the currently under-development anti-cancer drug, U3-1402*1, in combination with immune checkpoint inhibitors*2 has the potential to be an effective treatment.

Ground Breaking Development of World’s First CurativeTreatment of Intractable Hepatocellular Carcinoma Path to Establishment of Standard Treatment of Hepatocellular Carcinoma - Kindai University

Press releases   •   Aug 05, 2019 02:00 UTC

Senior Administrator Masatoshi Kudo of Kindai University Faculty of Medicine, Department of Gastroenterology and Hepatology, with his research group has invented a new method (LEN-TACE) of treating patients with intractable multinodular or large liver cancers, particularly those with near advanced liver cancer.